CANGIALOSI LORETTA V 4
4 · PFIZER INC · Filed Feb 28, 2020
Insider Transaction Report
Form 4
PFIZER INCPFE
CANGIALOSI LORETTA V
Sr. Vice President, Controller
Transactions
- Exercise/Conversion
Common Stock
2020-02-26$34.59/sh+24,155$835,521→ 131,196 total - Award
Common Stock
2020-02-26+3,797→ 134,993 total - Tax Payment
Common Stock
2020-02-26$34.72/sh−1,290$44,789→ 133,703 total - Tax Payment
Common Stock
2020-02-26$34.72/sh−1,943$67,461→ 131,760 total - Tax Payment
Common Stock
2020-02-26$36.80/sh−18,438$678,518→ 113,322 total - Exercise/Conversion
Stock Appreciation Rights
2020-02-26−24,155→ 0 totalExercise: $34.59From: 2020-02-26Exp: 2020-02-26→ Common Stock (24,155 underlying)
Holdings
- 2,666(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (6)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
- [F3]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
- [F4]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F5]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F6]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.